MedTrace Logo

Emotion Regulation as a Moderator of Two Different Treatments for Children With ODD

NCT06194994 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 196

Last updated 2024-01-08

No results posted yet for this study

Summary

The goal of this randomized controlled trial is to is to test emotion regulation as a moderator of two different treatments for children with Oppositional Defiant Disorder (ODD). The main question it aims to answer is whether treatment gains be increased when children with ODD receive a treatment congruent with their emotion regulation skill problems. Participants will be divided into two groups based on their response patterns; a high emotion dysregulation group and a low emotion dysregulation group. Within each group, children will then be randomly assigned to either a behavioral parent training intervention or a child directed treatment involving problem solving and emotion regulation skills.

Conditions

  • Oppositional Defiant Disorder

Interventions

BEHAVIORAL

Parent Management Training

Behavioral parent training program aimed at increasing compliance and positive behaviours while decreasing disruptive behaviours

BEHAVIORAL

Tuning Your Temper

Cognitive behavioural treatment for children focusing on arousal reduction, problem solving and cognitive restructuring.

Sponsors & Collaborators

  • Stockholm University

    collaborator OTHER

  • University of Iceland

    lead OTHER

Principal Investigators

  • Urdur Njardvik, PhD · Department of Psychology, University of Iceland

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-04
Primary Completion
2027-12-31
Completion
2029-12-31

Countries

  • Iceland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06194994 on ClinicalTrials.gov